Quanterix (QTRX) Non-Current Assets (2017 - 2026)
Quanterix (QTRX) posted Non-Current Assets of $180.9 million for Q1 2026, down 12.38% on a QoQ basis from $206.5 million in Q4 2025, and up 194.17% year-over-year from $61.5 million in Q1 2025.
Quanterix (QTRX) Non-Current Assets (2017 - 2026) Analysis & Trends
Quanterix's Non-Current Assets history runs 10 years deep, the most recent figure standing at $180.9 million for Q1 2026.
- Quarterly Non-Current Assets rose 194.17% year-over-year to $180.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $651.8 million (up 236.1% YoY) and the FY2025 annual result came in at $206.5 million, up 380.94% from the prior year.
- Non-Current Assets was $180.9 million for Q1 2026 at Quanterix, down from $206.5 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $210.9 million in Q3 2025 and bottomed at $42.9 million in Q4 2024.
- A 5-year average of $78.9 million and a median of $52.1 million in 2022 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2023 — Non-Current Assets sank 34.29% — and 2025, when it jumped 380.94%.
- Quanterix's Non-Current Assets stood at $52.1 million in 2022, then dropped by 10.73% to $46.5 million in 2023, then retreated by 7.6% to $42.9 million in 2024, then soared by 380.94% to $206.5 million in 2025, then slipped by 12.38% to $180.9 million in 2026.
- Business Quant data shows QTRX's Non-Current Assets at $180.9 million in Q1 2026, $206.5 million in Q4 2025, and $210.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | Quanterix | 184.16 Mn | 84.89 Mn | 15.57 Mn | 180.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 180.95 Mn |
| Dec 31, 2025 | 206.51 Mn |
| Sep 30, 2025 | 210.86 Mn |
| Jun 30, 2025 | 53.49 Mn |
| Mar 31, 2025 | 61.51 Mn |
| Dec 31, 2024 | 42.94 Mn |
| Sep 30, 2024 | 44.07 Mn |
| Jun 30, 2024 | 45.42 Mn |
| Mar 31, 2024 | 44.85 Mn |
| Dec 31, 2023 | 46.47 Mn |
| Sep 30, 2023 | 47.36 Mn |
| Jun 30, 2023 | 49.14 Mn |
| Mar 31, 2023 | 50.25 Mn |
| Dec 31, 2022 | 52.06 Mn |
| Sep 30, 2022 | 59.38 Mn |
| Jun 30, 2022 | 74.78 Mn |
| Mar 31, 2022 | 71.22 Mn |
| Dec 31, 2021 | 52.57 Mn |
| Sep 30, 2021 | 51.41 Mn |
| Jun 30, 2021 | 51.60 Mn |